
Scientists have made progress toward developing a diagnostic blood test for chronic traumatic encephalopathy (CTE), the degenerative brain disease caused by repeated head trauma. Historically, CTE could only be confirmed through autopsy after a patient’s death, limiting researchers’ ability to diagnose and treat the condition during a person’s lifetime.
In research published Thursday, investigators from Boston University’s CTE Center analyzed blood samples from 21 football players who had donated blood during their lifetimes and subsequently contributed their brains to the Boston University CTE Center Brain Bank. Eighteen of these individuals were confirmed to have CTE upon autopsy examination, with 16 displaying advanced disease. The researchers identified elevated levels of a specific form of the protein tau, known as eMTBR-tau, in the blood of those with confirmed CTE compared to individuals without the disease. Additionally, participants with advanced CTE demonstrated higher blood concentrations of this tau variant than those with mild CTE.
Gil Rabinovici Edward, a co-author from the University of California San Francisco, indicated in a statement that while further validation work remains necessary before the test could be implemented clinically, the findings represent a significant advancement. The discovery could eventually enable earlier diagnosis and intervention strategies for this serious neurological condition that affects individuals with histories of repeated head injuries, including athletes in contact sports.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI